SG55152A1 - Hepatitis b virus surface proteins with reduced host carbohydrate content - Google Patents
Hepatitis b virus surface proteins with reduced host carbohydrate contentInfo
- Publication number
- SG55152A1 SG55152A1 SG1996008131A SG1996008131A SG55152A1 SG 55152 A1 SG55152 A1 SG 55152A1 SG 1996008131 A SG1996008131 A SG 1996008131A SG 1996008131 A SG1996008131 A SG 1996008131A SG 55152 A1 SG55152 A1 SG 55152A1
- Authority
- SG
- Singapore
- Prior art keywords
- hbv
- surface proteins
- hepatitis
- carbohydrate content
- particles
- Prior art date
Links
- 241000700721 Hepatitis B virus Species 0.000 title abstract 7
- 102000018697 Membrane Proteins Human genes 0.000 title abstract 4
- 108010052285 Membrane Proteins Proteins 0.000 title abstract 4
- 150000001720 carbohydrates Chemical class 0.000 title abstract 3
- 239000002245 particle Substances 0.000 abstract 3
- 108700026244 Open Reading Frames Proteins 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 230000002950 deficient Effects 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 210000002845 virion Anatomy 0.000 abstract 1
- 210000005253 yeast cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/02—Hepadnaviridae, e.g. hepatitis B virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69292491A | 1991-04-29 | 1991-04-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG55152A1 true SG55152A1 (en) | 1998-12-21 |
Family
ID=24782605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996008131A SG55152A1 (en) | 1991-04-29 | 1992-04-29 | Hepatitis b virus surface proteins with reduced host carbohydrate content |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5614384A (de) |
| EP (1) | EP0516286B1 (de) |
| JP (1) | JP2637877B2 (de) |
| KR (1) | KR920019373A (de) |
| CN (1) | CN1067680A (de) |
| AT (1) | ATE215987T1 (de) |
| AU (1) | AU650530B2 (de) |
| BG (1) | BG61700B1 (de) |
| CA (1) | CA2067290A1 (de) |
| CZ (1) | CZ282769B6 (de) |
| DE (1) | DE69232541D1 (de) |
| FI (1) | FI934650A7 (de) |
| HU (1) | HUT69149A (de) |
| IE (1) | IE921385A1 (de) |
| IL (1) | IL101651A0 (de) |
| LT (1) | LT3367B (de) |
| MX (1) | MX9201970A (de) |
| NO (1) | NO933897L (de) |
| NZ (1) | NZ242487A (de) |
| PL (1) | PL171485B1 (de) |
| SG (1) | SG55152A1 (de) |
| SK (1) | SK118193A3 (de) |
| WO (1) | WO1992019741A1 (de) |
| YU (1) | YU45492A (de) |
| ZA (1) | ZA923069B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0533263A3 (en) * | 1991-09-20 | 1994-06-08 | Merck & Co Inc | A multivalent hepatitis b virus vaccine |
| WO1995031558A1 (en) * | 1994-05-16 | 1995-11-23 | Merck & Co., Inc. | Process for producing hbv surface proteins |
| US6300065B1 (en) * | 1996-05-31 | 2001-10-09 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| US6696251B1 (en) | 1996-05-31 | 2004-02-24 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| AU2212100A (en) * | 1998-12-23 | 2000-07-12 | Merck & Co., Inc. | Improved recombinant hepatitis b surface antigen |
| KR100604994B1 (ko) | 2004-01-30 | 2006-07-26 | 한국생명공학연구원 | 알파1,6-만노실트랜스퍼라제를 코딩하는 한세눌라폴리모르파 기원의 신규 유전자 및 상기 유전자가 결손된한세눌라 폴리모르파 변이주를 이용한 재조합 당단백질생산 방법 |
| CN111187720A (zh) * | 2019-12-27 | 2020-05-22 | 深圳康泰生物制品股份有限公司 | 表达肠道病毒71型抗原的重组汉逊酵母的细胞破碎方法及其在制备手足口病疫苗中的应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4803164A (en) * | 1981-08-31 | 1989-02-07 | Genentech, Inc. | Preparation of hepatitis b surface antigen in yeast |
| US4707542A (en) * | 1983-08-22 | 1987-11-17 | Merck & Co., Inc. | Immunogenic HbsAg derived from transformed yeast |
| US4816564A (en) * | 1986-01-31 | 1989-03-28 | Merck & Co., Inc. | Method for producing hepatitis B virus proteins in yeast |
| GB8613388D0 (en) * | 1986-06-03 | 1986-07-09 | Delta Biotechnology Ltd | Induction of galactose regulated gene expression in yeast |
| DE3719213C1 (de) * | 1987-06-09 | 1988-05-19 | Daimler Benz Ag | Bodennahe mehrpolige Stromversorgung fuer spurfuehrbare,gummibereifte,elektrisch antreibbare Fahrzeuge |
| US4963483A (en) * | 1987-10-13 | 1990-10-16 | Merck & Co., Inc. | Method for producing hepatitis B virus proteins in yeast |
| US5135854A (en) * | 1987-10-29 | 1992-08-04 | Zymogenetics, Inc. | Methods of regulating protein glycosylation |
| ATE100142T1 (de) * | 1987-10-29 | 1994-01-15 | Zymogenetics Inc | Verfahren zur regulierung der proteinglycosylierung. |
| GB8726953D0 (en) * | 1987-11-18 | 1987-12-23 | Delta Biotechnology Ltd | Yeast expression system |
| NZ229260A (en) * | 1988-06-03 | 1994-02-25 | Merck & Co Inc | Hepatitis b virus, expression cassette for pre-s domain, host cells and |
| EP0414374B1 (de) * | 1989-07-25 | 1997-10-08 | Smithkline Biologicals S.A. | Antigene sowie Verfahren zu deren Herstellung |
| CA2022109A1 (en) * | 1989-07-31 | 1991-02-01 | Cheryl A. Schulman | Enhanced expression of heterologous proteins in recombinant hosts in a non-growth media |
| CA2022108A1 (en) * | 1989-07-31 | 1991-02-01 | Cheryl A. Schulman | Enhanced growth and expression of heterologous proteins in recombinant hosts containing mutations in cell wall and/or plasma membrane biosynthesis |
| DE69013471T2 (de) * | 1989-12-05 | 1995-03-30 | Merck & Co Inc | Methode zur Stabilisierung von rekombinanten Hepatitis-B-Virus-Oberflächenproteinen aus Hefe. |
| IL101653A0 (en) * | 1991-04-29 | 1992-12-30 | Merck & Co Inc | Multiple hepatitis b virus surface proteins which form particles |
-
1992
- 1992-04-20 IL IL101651A patent/IL101651A0/xx unknown
- 1992-04-24 NZ NZ24248792A patent/NZ242487A/en unknown
- 1992-04-27 CZ CS932271A patent/CZ282769B6/cs not_active IP Right Cessation
- 1992-04-27 SK SK1181-93A patent/SK118193A3/sk unknown
- 1992-04-27 WO PCT/US1992/003472 patent/WO1992019741A1/en not_active Ceased
- 1992-04-27 CA CA002067290A patent/CA2067290A1/en not_active Abandoned
- 1992-04-27 PL PL92301163A patent/PL171485B1/pl unknown
- 1992-04-27 HU HU9303064A patent/HUT69149A/hu unknown
- 1992-04-28 MX MX9201970A patent/MX9201970A/es unknown
- 1992-04-28 ZA ZA923069A patent/ZA923069B/xx unknown
- 1992-04-28 KR KR1019920007142A patent/KR920019373A/ko not_active Ceased
- 1992-04-28 AU AU15222/92A patent/AU650530B2/en not_active Ceased
- 1992-04-28 YU YU45492A patent/YU45492A/sh unknown
- 1992-04-28 CN CN92104290A patent/CN1067680A/zh active Pending
- 1992-04-29 SG SG1996008131A patent/SG55152A1/en unknown
- 1992-04-29 AT AT92303883T patent/ATE215987T1/de active
- 1992-04-29 EP EP92303883A patent/EP0516286B1/de not_active Expired - Lifetime
- 1992-04-29 DE DE69232541T patent/DE69232541D1/de not_active Expired - Lifetime
- 1992-04-30 JP JP4155566A patent/JP2637877B2/ja not_active Expired - Fee Related
- 1992-07-01 IE IE138592A patent/IE921385A1/en not_active Application Discontinuation
-
1993
- 1993-03-30 LT LTIP462A patent/LT3367B/lt not_active IP Right Cessation
- 1993-10-21 FI FI934650A patent/FI934650A7/fi unknown
- 1993-10-28 NO NO933897A patent/NO933897L/no not_active Application Discontinuation
- 1993-10-29 BG BG98187A patent/BG61700B1/bg unknown
-
1995
- 1995-01-04 US US08/368,287 patent/US5614384A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| MX9201970A (es) | 1992-11-01 |
| CA2067290A1 (en) | 1992-10-30 |
| CZ227193A3 (en) | 1994-04-13 |
| SK118193A3 (en) | 1994-03-09 |
| WO1992019741A1 (en) | 1992-11-12 |
| NO933897D0 (no) | 1993-10-28 |
| HUT69149A (en) | 1995-08-28 |
| IE921385A1 (en) | 1992-11-04 |
| CZ282769B6 (cs) | 1997-10-15 |
| ZA923069B (en) | 1992-12-30 |
| CN1067680A (zh) | 1993-01-06 |
| EP0516286A1 (de) | 1992-12-02 |
| HU9303064D0 (en) | 1994-03-28 |
| LT3367B (en) | 1995-08-25 |
| BG61700B1 (bg) | 1998-03-31 |
| PL171485B1 (pl) | 1997-05-30 |
| FI934650A0 (fi) | 1993-10-21 |
| NZ242487A (en) | 1994-07-26 |
| JP2637877B2 (ja) | 1997-08-06 |
| BG98187A (bg) | 1994-06-30 |
| FI934650A7 (fi) | 1993-10-21 |
| AU1522292A (en) | 1993-03-11 |
| LTIP462A (en) | 1994-10-25 |
| DE69232541D1 (de) | 2002-05-16 |
| YU45492A (sh) | 1994-06-10 |
| KR920019373A (ko) | 1992-11-19 |
| JPH06141872A (ja) | 1994-05-24 |
| NO933897L (no) | 1993-10-28 |
| AU650530B2 (en) | 1994-06-23 |
| EP0516286B1 (de) | 2002-04-10 |
| US5614384A (en) | 1997-03-25 |
| ATE215987T1 (de) | 2002-04-15 |
| IL101651A0 (en) | 1992-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1993014208A3 (en) | Hepatitis e virus vaccine and method | |
| LU91388I2 (en) | Papillomavirus (humain types 16,18). | |
| HU9202753D0 (en) | Process for producing recombinant avain poxvirus and vaccine comprising same | |
| AU576907B2 (en) | Oral vaccines comprising live recombinant adenoviruses | |
| ZA923069B (en) | Hepatitis b virus surface proteins with reduced host carbohydrate content | |
| YU45292A (sh) | Različiti površinski proteini hepatitis b virusa koji obrazuju čestice | |
| AU3422797A (en) | Composition useful in preparing recombinant adenovirus vaccines | |
| CA2116355A1 (en) | Infectious bovine rhinotracheitis virus mutants and vaccines | |
| ATE102650T1 (de) | Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung. | |
| CA2105277A1 (en) | Genetically engineered vaccine strain | |
| NZ295056A (en) | Hepatitis virus e strain, recombinant proteins thereof, use in diagnostic methods and vaccines | |
| IL100386A0 (en) | Cell free marek's disease virus vaccine | |
| EP0288198A3 (de) | Peptidherstellung | |
| RU93058279A (ru) | Система экспрессии, белок, вакцина, реагент | |
| DK257887D0 (da) | Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden | |
| EP0485347A3 (en) | Recombinant hepatitis delta antigen, process for the purification and use thereof | |
| Pérez et al. | Synthesis and secretion of the hepatitis B surface antigen in mammalian cells. | |
| Tron | Hepatitis B virus recombinant vaccines: achievement and progress | |
| YU30495A (sh) | Postupak za dobijanje hbv površinskih proteina | |
| Seong | Effects of Addition of Sugars on the Stability of Hepatitis B Virus Vaccine | |
| EP0503252A3 (en) | Recombinant proteins having the immunoreactivity of hepatitis b virus e antigens (hbeag), method for their production and their application in immunoassays and as vaccines | |
| CA2558659A1 (en) | Genetically engineered canary poxvirus-based vaccine strain |